AAP
IDXX icon

Arax Advisory Partners’s Idexx Laboratories IDXX Stock Holding History

Arax Advisory Partners’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$913K Buy
1,735
+1,685
+3,370% +$945K 0.01% 1262
2026
Q1 		$27.1K Sell
50
-178
-78% -$114K ﹤0.01% 1954
2025
Q4 		$154K Sell
228
-2,025
-90% -$1.38M ﹤0.01% 1139
2025
Q3 		$1.44M Buy
2,253
+2,059
+1,061% +$1.25M 0.02% 542
2025
Q2 		$104K Buy
194
+107
+123% +$51.2K ﹤0.01% 917
2025
Q1 		$36.5K Sell
87
-279
-76% -$121K ﹤0.01% 1069
2024
Q4 		$151K Buy
366
+287
+363% +$126K 0.01% 559
2024
Q3 		$39.9K Sell
79
-17
-18% -$8.26K ﹤0.01% 802
2024
Q2 		$46.8K Buy
96
+92
+2,300% +$46.2K ﹤0.01% 686
2024
Q1 		$2.16K Buy
4
+2
+100% +$1.09K ﹤0.01% 1025
2023
Q4 		$1.11K Buy
+2
New +$939 ﹤0.01% 1122
2023
Q3 		– Sell
-1
Closed -$503 – 1337
2023
Q2 		$503 Sell
1
-247
-100% -$118K ﹤0.01% 1208
2023
Q1 		$124K Sell
248
-134
-35% -$64.1K 0.02% 317
2022
Q4 		$156K Sell
382
-41
-10% -$15.9K 0.02% 262
2022
Q3 		$138K Sell
423
-10
-2% -$3.67K 0.02% 263
2022
Q2 		$152K Buy
433
+76
+21% +$31K 0.02% 254
2022
Q1 		$195K Buy
357
+16
+5% +$8.42K 0.03% 248
2021
Q4 		$225K Hold
341
– – 0.03% 228
2021
Q3 		$212K Sell
341
-41
-11% -$27.6K 0.03% 228
2021
Q2 		$241K Buy
+382
New +$211K 0.03% 217
2020
Q4 		$179K Buy
359
+4
+1% +$1.79K 0.03% 221
2020
Q3 		$140K Buy
355
+99
+39% +$36.6K 0.02% 224
2020
Q2 		$85K Buy
256
+244
+2,033% +$70.6K 0.02% 281
2020
Q1 		$3K Buy
+12
New +$3.13K ﹤0.01% 606

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Arax Advisory Partners's IDXX Position: Q2 2026 in Review

Arax Advisory Partners increased its Idexx Laboratories (IDXX) stake by 3,370% in Q2 2026, buying an estimated $945K and bringing the position to 1,735 shares worth $913K. The position accounts for 0.01% of the portfolio, ranked #1262.

Arax Advisory Partners first reported a position in IDXX in Q1 2020 and has held it in 24 quarters since. The position peaked at $1.44M in Q3 2025. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Arax Advisory Partners held 1,735 shares of Idexx Laboratories worth $913K as of Q2 2026.
  • Arax Advisory Partners bought 1,685 Idexx Laboratories shares in Q2 2026, an estimated $945K.
  • Idexx Laboratories made up 0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #1262 holding.
  • Arax Advisory Partners first reported a position in Idexx Laboratories in Q1 2020 and has held it in 24 quarters since.
  • Arax Advisory Partners's Idexx Laboratories position peaked at $1.44M in Q3 2025.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.